Akoya Biosciences, Inc. Provides Revenue Guidance for the Fourth Quarter and Fiscal Year 2022
For the fiscal year of 2022, revenue is expected to be between $74.3 million and $74.8 million, as compared to $54.9 million for fiscal year 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.34 USD | -4.10% |
|
-0.85% | -52.05% |
1st Jan change | Capi. | |
---|---|---|
-52.05% | 12Cr | |
+8.00% | 19TCr | |
+31.86% | 16TCr | |
+33.21% | 11TCr | |
+2.28% | 6.43TCr | |
+21.14% | 5.57TCr | |
+0.11% | 4.84TCr | |
-6.76% | 3.78TCr | |
+0.78% | 3.56TCr | |
+11.28% | 2.81TCr |